English
简体中文
Total: £ 56.28
Published Date: 2024-08-07 | Pages: 109 | Tables: 137 | Medical Care
ADCs are mainly composed of three parts: antibodies, linkers, and cytotoxic loads. They are a type of bioactive cytotoxic drugs that are linked to monoclonal antibodies through chemical bonds and use monoclonal antibodies as carriers to target and transport cytotoxic drugs to target cells. Complex that works. The design concept of ADC was first proposed by Paul Ehrlich in the early 20th century. In 2000, the U.S. Food and Drug Administration (FDA) approved the first ADC drug, Mylotarg® (gemtuzumab ozogamicin), for the treatment of acute myeloid myelopathy in adults. Leukemic cell lines, marking the beginning of the era of ADC-targeted cancer therapy.
Market Analysis and Insights: Global Antibody Drug Conjugates Contract Manufacturing Market
The global Antibody Drug Conjugates Contract Manufacturing market is projected to grow from US$ 3301.3 million in 2024 to US$ 9332.5 million by 2030, at a Compound Annual Growth Rate (CAGR) of 18.9% during the forecast period.
Key global companies of Antibody Drug Conjugates Contract Manufacturing (ADC) include Lonza, Merck, Recipharm, Thermo Fisher, AbbVie, Piramal Pharma Solutions, Catalent, Sterling Pharma Solutions and Curia. The top three players are Lonza, Merck and Recipharm, which together account for about 50% of the global market share. The largest player is Lonza Group. From the production side, the global players are mainly concentrated in North America and Europe. North America accounts for about 35% of the global market share. In terms of type, IgG1 dominates the global antibody drug conjugate contract manufacturing market. In terms of application, solid tumor applications account for more than half of the market.
Report Covers:
This report presents an overview of global market for Antibody Drug Conjugates Contract Manufacturing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Antibody Drug Conjugates Contract Manufacturing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Antibody Drug Conjugates Contract Manufacturing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Antibody Drug Conjugates Contract Manufacturing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Antibody Drug Conjugates Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Antibody Drug Conjugates Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Lonza Group
Merck KGaA
Recipharm
Thermo Fisher Scientific
Abbvie
Piramal Pharma Solutions
Catalent
Sterling Pharma Solutions
Curia
Novasep
Ajinomoto Bio-Pharma Services
BSP Pharmaceuticals
Cerbios-Pharma
Goodwin Biotechnology
Segment by Type
IgG1
IgG4
Segment by Application
Solid Tumors
Hematological Malignancies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Antibody Drug Conjugates Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Drug Conjugates Contract Manufacturing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibody Drug Conjugates Contract Manufacturing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 IgG1
1.2.3 IgG4
1.3 Market by Application
1.3.1 Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Solid Tumors
1.3.3 Hematological Malignancies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Drug Conjugates Contract Manufacturing Market Perspective (2019-2030)
2.2 Global Antibody Drug Conjugates Contract Manufacturing Growth Trends by Region
2.2.1 Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Region (2019-2024)
2.2.3 Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2025-2030)
2.3 Antibody Drug Conjugates Contract Manufacturing Market Dynamics
2.3.1 Antibody Drug Conjugates Contract Manufacturing Industry Trends
2.3.2 Antibody Drug Conjugates Contract Manufacturing Market Drivers
2.3.3 Antibody Drug Conjugates Contract Manufacturing Market Challenges
2.3.4 Antibody Drug Conjugates Contract Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Antibody Drug Conjugates Contract Manufacturing by Players
3.1.1 Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2019-2024)
3.1.2 Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Drug Conjugates Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio
3.4.1 Global Antibody Drug Conjugates Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Drug Conjugates Contract Manufacturing Revenue in 2023
3.5 Global Key Players of Antibody Drug Conjugates Contract Manufacturing Head office and Area Served
3.6 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application
3.7 Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Type
4.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Type (2019-2024)
4.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2025-2030)
5 Antibody Drug Conjugates Contract Manufacturing Breakdown Data by Application
5.1 Global Antibody Drug Conjugates Contract Manufacturing Historic Market Size by Application (2019-2024)
5.2 Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size (2019-2030)
6.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type
6.2.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024)
6.2.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030)
6.2.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
6.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application
6.3.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024)
6.3.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030)
6.3.3 North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
6.4 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
6.4.1 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2019-2024)
6.4.3 North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size (2019-2030)
7.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type
7.2.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024)
7.2.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030)
7.2.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
7.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application
7.3.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024)
7.3.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030)
7.3.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
7.4 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country
7.4.1 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2019-2024)
7.4.3 Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Antibody Drug Conjugates Contract Manufacturing Market Size (2019-2030)
8.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type
8.2.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024)
8.2.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030)
8.2.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
8.3 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application
8.3.1 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024)
8.3.2 China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030)
8.3.3 China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size (2019-2030)
9.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type
9.2.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024)
9.2.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030)
9.2.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
9.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application
9.3.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024)
9.3.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030)
9.3.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
9.4 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region
9.4.1 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2019-2024)
9.4.3 Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type
10.2.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application
10.3.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country
10.4.1 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Antibody Drug Conjugates Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.1.5 Lonza Group Recent Developments
11.2 Merck KGaA
11.2.1 Merck KGaA Company Details
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Antibody Drug Conjugates Contract Manufacturing Introduction
11.2.4 Merck KGaA Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.2.5 Merck KGaA Recent Developments
11.3 Recipharm
11.3.1 Recipharm Company Details
11.3.2 Recipharm Business Overview
11.3.3 Recipharm Antibody Drug Conjugates Contract Manufacturing Introduction
11.3.4 Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.3.5 Recipharm Recent Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Introduction
11.4.4 Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Developments
11.5 Abbvie
11.5.1 Abbvie Company Details
11.5.2 Abbvie Business Overview
11.5.3 Abbvie Antibody Drug Conjugates Contract Manufacturing Introduction
11.5.4 Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.5.5 Abbvie Recent Developments
11.6 Piramal Pharma Solutions
11.6.1 Piramal Pharma Solutions Company Details
11.6.2 Piramal Pharma Solutions Business Overview
11.6.3 Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
11.6.4 Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.6.5 Piramal Pharma Solutions Recent Developments
11.7 Catalent
11.7.1 Catalent Company Details
11.7.2 Catalent Business Overview
11.7.3 Catalent Antibody Drug Conjugates Contract Manufacturing Introduction
11.7.4 Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.7.5 Catalent Recent Developments
11.8 Sterling Pharma Solutions
11.8.1 Sterling Pharma Solutions Company Details
11.8.2 Sterling Pharma Solutions Business Overview
11.8.3 Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Introduction
11.8.4 Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.8.5 Sterling Pharma Solutions Recent Developments
11.9 Curia
11.9.1 Curia Company Details
11.9.2 Curia Business Overview
11.9.3 Curia Antibody Drug Conjugates Contract Manufacturing Introduction
11.9.4 Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.9.5 Curia Recent Developments
11.10 Novasep
11.10.1 Novasep Company Details
11.10.2 Novasep Business Overview
11.10.3 Novasep Antibody Drug Conjugates Contract Manufacturing Introduction
11.10.4 Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.10.5 Novasep Recent Developments
11.11 Ajinomoto Bio-Pharma Services
11.11.1 Ajinomoto Bio-Pharma Services Company Details
11.11.2 Ajinomoto Bio-Pharma Services Business Overview
11.11.3 Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Introduction
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.11.5 Ajinomoto Bio-Pharma Services Recent Developments
11.12 BSP Pharmaceuticals
11.12.1 BSP Pharmaceuticals Company Details
11.12.2 BSP Pharmaceuticals Business Overview
11.12.3 BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Introduction
11.12.4 BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.12.5 BSP Pharmaceuticals Recent Developments
11.13 Cerbios-Pharma
11.13.1 Cerbios-Pharma Company Details
11.13.2 Cerbios-Pharma Business Overview
11.13.3 Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Introduction
11.13.4 Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.13.5 Cerbios-Pharma Recent Developments
11.14 Goodwin Biotechnology
11.14.1 Goodwin Biotechnology Company Details
11.14.2 Goodwin Biotechnology Business Overview
11.14.3 Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Introduction
11.14.4 Goodwin Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
11.14.5 Goodwin Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Key Players of IgG1
Table 3. Key Players of IgG4
Table 4. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2019-2024)
Table 8. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2025-2030)
Table 10. Antibody Drug Conjugates Contract Manufacturing Market Trends
Table 11. Antibody Drug Conjugates Contract Manufacturing Market Drivers
Table 12. Antibody Drug Conjugates Contract Manufacturing Market Challenges
Table 13. Antibody Drug Conjugates Contract Manufacturing Market Restraints
Table 14. Global Antibody Drug Conjugates Contract Manufacturing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Players (2019-2024)
Table 16. Global Top Antibody Drug Conjugates Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2023)
Table 17. Global Antibody Drug Conjugates Contract Manufacturing Industry Ranking 2022 VS 2023 VS 2024
Table 18. Global 5 Largest Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Headquarters and Area Served
Table 20. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application
Table 21. Global Key Players of Antibody Drug Conjugates Contract Manufacturing, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2019-2024)
Table 25. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Antibody Drug Conjugates Contract Manufacturing Revenue Market Share by Type (2025-2030)
Table 27. Global Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Application (2019-2024)
Table 29. Global Antibody Drug Conjugates Contract Manufacturing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Antibody Drug Conjugates Contract Manufacturing Revenue Share by Application (2025-2030)
Table 31. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 32. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 33. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 34. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 35. North America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 37. North America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 39. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 40. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 41. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 42. Europe Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 44. Europe Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 45. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 46. China Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 47. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 48. China Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 49. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 50. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 51. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 52. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 53. Asia Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 54. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2019-2024) & (US$ Million)
Table 55. Asia Antibody Drug Conjugates Contract Manufacturing Market Size by Region (2025-2030) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2019-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Type (2025-2030) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2019-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Application (2025-2030) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 61. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2019-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size by Country (2025-2030) & (US$ Million)
Table 63. Lonza Group Company Details
Table 64. Lonza Group Business Overview
Table 65. Lonza Group Antibody Drug Conjugates Contract Manufacturing Product
Table 66. Lonza Group Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 67. Lonza Group Recent Developments
Table 68. Merck KGaA Company Details
Table 69. Merck KGaA Business Overview
Table 70. Merck KGaA Antibody Drug Conjugates Contract Manufacturing Product
Table 71. Merck KGaA Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 72. Merck KGaA Recent Developments
Table 73. Recipharm Company Details
Table 74. Recipharm Business Overview
Table 75. Recipharm Antibody Drug Conjugates Contract Manufacturing Product
Table 76. Recipharm Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 77. Recipharm Recent Developments
Table 78. Thermo Fisher Scientific Company Details
Table 79. Thermo Fisher Scientific Business Overview
Table 80. Thermo Fisher Scientific Antibody Drug Conjugates Contract Manufacturing Product
Table 81. Thermo Fisher Scientific Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 82. Thermo Fisher Scientific Recent Developments
Table 83. Abbvie Company Details
Table 84. Abbvie Business Overview
Table 85. Abbvie Antibody Drug Conjugates Contract Manufacturing Product
Table 86. Abbvie Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 87. Abbvie Recent Developments
Table 88. Piramal Pharma Solutions Company Details
Table 89. Piramal Pharma Solutions Business Overview
Table 90. Piramal Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product
Table 91. Piramal Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 92. Piramal Pharma Solutions Recent Developments
Table 93. Catalent Company Details
Table 94. Catalent Business Overview
Table 95. Catalent Antibody Drug Conjugates Contract Manufacturing Product
Table 96. Catalent Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 97. Catalent Recent Developments
Table 98. Sterling Pharma Solutions Company Details
Table 99. Sterling Pharma Solutions Business Overview
Table 100. Sterling Pharma Solutions Antibody Drug Conjugates Contract Manufacturing Product
Table 101. Sterling Pharma Solutions Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 102. Sterling Pharma Solutions Recent Developments
Table 103. Curia Company Details
Table 104. Curia Business Overview
Table 105. Curia Antibody Drug Conjugates Contract Manufacturing Product
Table 106. Curia Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 107. Curia Recent Developments
Table 108. Novasep Company Details
Table 109. Novasep Business Overview
Table 110. Novasep Antibody Drug Conjugates Contract Manufacturing Product
Table 111. Novasep Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 112. Novasep Recent Developments
Table 113. Ajinomoto Bio-Pharma Services Company Details
Table 114. Ajinomoto Bio-Pharma Services Business Overview
Table 115. Ajinomoto Bio-Pharma Services Antibody Drug Conjugates Contract Manufacturing Product
Table 116. Ajinomoto Bio-Pharma Services Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 117. Ajinomoto Bio-Pharma Services Recent Developments
Table 118. BSP Pharmaceuticals Company Details
Table 119. BSP Pharmaceuticals Business Overview
Table 120. BSP Pharmaceuticals Antibody Drug Conjugates Contract Manufacturing Product
Table 121. BSP Pharmaceuticals Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 122. BSP Pharmaceuticals Recent Developments
Table 123. Cerbios-Pharma Company Details
Table 124. Cerbios-Pharma Business Overview
Table 125. Cerbios-Pharma Antibody Drug Conjugates Contract Manufacturing Product
Table 126. Cerbios-Pharma Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 127. Cerbios-Pharma Recent Developments
Table 128. Goodwin Biotechnology Company Details
Table 129. Goodwin Biotechnology Business Overview
Table 130. Goodwin Biotechnology Antibody Drug Conjugates Contract Manufacturing Product
Table 131. Goodwin Biotechnology Revenue in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024) & (US$ Million)
Table 132. Goodwin Biotechnology Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 2. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Type: 2023 VS 2030
Figure 3. IgG1 Features
Figure 4. IgG4 Features
Figure 5. Global Antibody Drug Conjugates Contract Manufacturing Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 6. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Application: 2023 VS 2030
Figure 7. Solid Tumors Case Studies
Figure 8. Hematological Malignancies Case Studies
Figure 9. Antibody Drug Conjugates Contract Manufacturing Report Years Considered
Figure 10. Global Antibody Drug Conjugates Contract Manufacturing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Antibody Drug Conjugates Contract Manufacturing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Region: 2023 VS 2030
Figure 13. Global Antibody Drug Conjugates Contract Manufacturing Market Share by Players in 2023
Figure 14. Global Top Antibody Drug Conjugates Contract Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibody Drug Conjugates Contract Manufacturing as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Antibody Drug Conjugates Contract Manufacturing Revenue in 2023
Figure 16. North America Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
Figure 18. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
Figure 19. North America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2019-2030)
Figure 20. United States Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Antibody Drug Conjugates Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 23. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
Figure 24. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
Figure 25. Europe Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2019-2030)
Figure 26. Germany Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. China Antibody Drug Conjugates Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 33. China Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
Figure 34. China Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
Figure 35. Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 36. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
Figure 37. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
Figure 38. Asia Antibody Drug Conjugates Contract Manufacturing Market Share by Region (2019-2030)
Figure 39. Japan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. South Korea Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. China Taiwan Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Southeast Asia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. India Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Australia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Size YoY (2019-2030) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Type (2019-2030)
Figure 47. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Application (2019-2030)
Figure 48. Middle East, Africa, and Latin America Antibody Drug Conjugates Contract Manufacturing Market Share by Country (2019-2030)
Figure 49. Brazil Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Mexico Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Turkey Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 53. Israel Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 54. GCC Countries Antibody Drug Conjugates Contract Manufacturing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 55. Lonza Group Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 56. Merck KGaA Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 57. Recipharm Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 58. Thermo Fisher Scientific Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 59. Abbvie Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 60. Piramal Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 61. Catalent Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 62. Sterling Pharma Solutions Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 63. Curia Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 64. Novasep Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 65. Ajinomoto Bio-Pharma Services Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 66. BSP Pharmaceuticals Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 67. Cerbios-Pharma Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 68. Goodwin Biotechnology Revenue Growth Rate in Antibody Drug Conjugates Contract Manufacturing Business (2019-2024)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed
